70 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
T. Rowe Price (TROW) to Post Q4 Earnings: What's in the Cards? https://www.zacks.com/stock/news/2219670/t-rowe-price-trow-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219670 Feb 01, 2024 - T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the fourth quarter of 2023 due to favourable equity market performance partially offset by net outflows.
T. Rowe Price (TROW) Expected to Beat Earnings Estimates: Should You Buy? https://www.zacks.com/stock/news/2219608/t-rowe-price-trow-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219608 Feb 01, 2024 - T. Rowe (TROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Samsung C&T investors pushing for dividend, share buybacks https://seekingalpha.com/news/4062217-samsung-ct-investors-pushing-for-dividends-share-buybacks?source=feed_sector_healthcare Feb 02, 2024 - Investors urge Samsung to increase dividends and begin share repurchase plan.
Want to Gain $1,000 in Annual Dividend Income? Invest $11,900 in These 3 High-Yield Dividend Stocks. https://www.fool.com/investing/2024/02/04/want-to-gain-1000-in-annual-dividend-income-invest/?source=iedfolrf0000001 Feb 04, 2024 - Building up a passive income stream could be easier than you expect.
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC https://www.zacks.com/stock/news/2221922/bristol-myers-bmy-tsvt-car-t-cell-therapy-to-face-fda-s-odac?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221922 Feb 06, 2024 - Bristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review data supporting the label expansion for CAR T-cell therapy.
T. Rowe Price (TROW) Q4 Earnings Beat Estimates, AUM Rises Y/Y https://www.zacks.com/stock/news/2223559/t-rowe-price-trow-q4-earnings-beat-estimates-aum-rises-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2223559 Feb 08, 2024 - T. Rowe Price's (TROW) Q4 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.
3 Cheap Tech Stocks to Buy Right Now https://www.fool.com/investing/2024/02/12/3-cheap-tech-stocks-to-buy-right-now/?source=iedfolrf0000001 Feb 12, 2024 - IBM, AT&T, and Cisco are all attractive safe haven plays.
Want Better Returns? Don?t Ignore These 2 Consumer Discretionary Stocks Set to Beat Earnings https://www.zacks.com/stock/news/2227782/want-better-returns-don-t-ignore-these-2-consumer-discretionary-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2227782 Feb 19, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353 Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
W&T (WTI) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2236364/w-t-wti-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2236364 Mar 05, 2024 - While the top- and bottom-line numbers for W&T (WTI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Pages: 1234567

<<<Page 6